| Dec'17 | ||||||
|---|---|---|---|---|---|---|
Class of Stock | ||||||
Class of Stock | ||||||
Series C Convertible Redeemable Preferred Shares | ||||||
Products and Services | ||||||
Products and Services | ||||||
Alternative Investment Product | ||||||
Counterparty Name | ||||||
Counterparty Name | ||||||
Consolidated Trust | ||||||
Cash flows from operating activities: | ||||||
Net profit (loss) | ||||||
166,440 | ||||||
Adjustments to reconcile net profit (loss) to net cash provided by (used in) operating activities: | ||||||
Provision for loan losses | ||||||
7,160 | ||||||
Depreciation and amortization | ||||||
3,466 | ||||||
Gain from quality assurance fund | ||||||
904 | ||||||
Realized gain from financial guarantee derivatives | ||||||
25,991 | ||||||
Change in fair value of financial guarantee derivative | ||||||
-58,875 | ||||||
Expected discretionary payment to IRF investors | ||||||
16,547 | ||||||
Share-based compensation | ||||||
16,315 | ||||||
Changes in operating assets and liabilities: | ||||||
Deferred revenue | ||||||
15,707 | ||||||
Accounts receivable | ||||||
550 | ||||||
Prepaid expenses and other assets | ||||||
16,285 | ||||||
Due to related party | ||||||
-563 | ||||||
Accrued expenses and other liabilities | ||||||
16,668 | ||||||
Payroll and welfare payable | ||||||
11,112 | ||||||
Taxes payable | ||||||
26,426 | ||||||
Deferred tax asset | ||||||
14,854 | ||||||
Transferred from restricted cash due to maturity of investment program | ||||||
7,004 | ||||||
Net cash provided by (used in) operating activities | ||||||
286,573 | ||||||
Cash flows from investing activities: | ||||||
Collection of loans originated and held by the Group | ||||||
49,825 | ||||||
Investment in loans originated and held by the Group | ||||||
157,223 | ||||||
Purchase of property, equipment and software | ||||||
13,967 | ||||||
Purchase of equity investments | ||||||
991 | ||||||
Purchase of available-for-sale securities | ||||||
539 | ||||||
Proceeds from short-term investments | ||||||
996,809 | ||||||
Purchase of short-term investments | ||||||
1,252,240 | ||||||
Proceeds from disposal of a subsidiary | ||||||
922 | ||||||
Cash paid for business combinations, net of cash acquired | ||||||
6,160 | ||||||
Net cash used in investing activities | ||||||
-383,564 | ||||||
Cash flows from financing activities: | ||||||
Cash paid for repurchase of the consolidated trusts | ||||||
4,803 | ||||||
Proceeds from issuance of ordinary share, net | ||||||
257,784 | ||||||
Net cash provided by financing activities | ||||||
327,826 | ||||||
Effect of exchange rate changes on cash and cash equivalents | ||||||
-2,372 | ||||||
Net increase in cash and cash equivalents | ||||||
228,463 | ||||||
Supplemental disclosure of cash flow information | ||||||
Cash paid for interest including paid to investors of consolidated trusts | ||||||
826 | ||||||
Cash paid for income taxes | ||||||
33,208 | ||||||
Supplemental disclosure of non-cash investing and financing activities | ||||||
Accretion on convertible redeemable preferred shares to redemption value | ||||||
472,384 | ||||||
Contributions into quality assurance fund and investor reserve funds | ||||||
407,072 | ||||||
Net Payouts of quality assurance fund payable | ||||||
-269,025 | ||||||
Payable for purchase of property, equipment and software | ||||||
1,012 | ||||||